tiprankstipranks
Trending News
More News >
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market

Monopar Therapeutics Inc (MNPR) Financial Statements

Compare
557 Followers

Monopar Therapeutics Inc Financial Overview

Monopar Therapeutics Inc's market cap is currently $465.11M. The company's EPS TTM is $-0.48; its P/E ratio is -20.24; Monopar Therapeutics Inc is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -16.16M$ -8.83M$ -10.54M$ -9.13M$ -6.51M
EBITDA$ -16.16M$ -8.83M$ -10.54M$ -9.13M$ 0.00
Net Income$ -15.59M$ -8.40M$ -10.52M$ -9.10M$ -6.30M
Balance Sheet
Cash & Short-Term Investments$ 60.21M$ 7.27M$ 13.12M$ 20.30M$ 16.74M
Total Assets$ 60.29M$ 7.35M$ 13.23M$ 20.52M$ 16.87M
Total Debt$ 0.00$ 0.00$ 8.41K$ 0.00$ 0.00
Net Debt$ -45.82M$ -7.27M$ -8.18M$ -20.30M$ -16.74M
Total Liabilities$ 5.25M$ 1.76M$ 3.14M$ 1.58M$ 1.18M
Stockholders' Equity$ 55.04M$ 5.59M$ 10.09M$ 18.94M$ 15.69M
Cash Flow
Free Cash Flow$ -6.40M$ -7.86M$ -7.23M$ -7.32M$ -4.66M
Operating Cash Flow$ -6.40M$ -7.86M$ -7.23M$ -7.32M$ -4.66M
Investing Cash Flow$ -14.34M$ 4.93M$ -4.92M$ 0.00$ 0.00
Financing Cash Flow$ 59.29M$ 2.03M$ 32.87K$ 10.88M$ 8.18M
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

Monopar Therapeutics Inc Debt to Assets

Monopar Therapeutics Inc Cash Flow

Monopar Therapeutics Inc Forecast EPS vs Actual EPS